Financhill
Back

Spero Therapeutics 10K Form

Sell
47

SPRO
Spero Therapeutics

Last Price:
$3.00
Seasonality Move:
12.43%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SPRO News And Ratings

See the #1 stock for the next 7 days that we like better than SPRO

SPRO Financial Statistics

Sales & Book Value

Annual Sales: $27.4M
Cash Flow: $-4M
Price / Cash Flow: 0
Annual Sales: $0.60
Price / Book: 5.03

Profitability

EPS (TTM): -1.28000
Net Income (TTM): $-69.8M
Gross Margin: $7.4M
Return on Equity: -108.26%
Return on Assets: -54.42%

Spero Therapeutics Earnings Forecast

Key Spero Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 10 years for SPRO is 54.81%.
  • The Selling, General & Administrative Expenses for SPRO have been equal to 86.52% of Gross Profit Margin.
  • The Research & Development expenses have been 353.18% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of SPRO is -250.28% of Total Revenues.
  • Per Share Earnings over the last 20 years have been positive in 8 years.

Spero Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: SPRO
CUSIP: 84833T
Website: sperotherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.56
Quick Ratio: 2.51

Price-to-Earnings

Trailing P/E Ratio: 2
Forward P/E Ratio: 0

SPRO Technical Analysis vs Fundamental Analysis

Sell
47
Spero Therapeutics (SPRO) is a Sell

Is Spero Therapeutics a Buy or a Sell?